NAV26/04/2024 Var.-0.3200 Type of yield Focus sugli investimenti Società d'investimento
283.1600EUR -0.11% reinvestment Equity Worldwide JPMorgan AM (EU) 

Investment strategy

To achieve a return by investing primarily in pharmaceutical, biotechnology, healthcare services, medical technology and life sciences companies ("Healthcare Companies"), globally. At least 67% of assets invested in Healthcare Companies anywhere in the world. The Sub-Fund may invest in smaller capitalisation companies. At least 51% of assets are invested in companies with positive environmental and/or social characteristics that follow good governance practices as measured through the Investment Manager's proprietary ESG scoring methodology and/or third party data.
 

Investment goal

To achieve a return by investing primarily in pharmaceutical, biotechnology, healthcare services, medical technology and life sciences companies ("Healthcare Companies"), globally.
 

Dati master

Type of yield: reinvestment
Fondi Categoria: Equity
Region: Worldwide
Settore: Sector Health / Pharma
Benchmark: MSCI World Healthcare Index (Total Return Net)
Business year start: 01/07
Ultima distribuzione: -
Banca depositaria: J.P. Morgan Bank Luxembourg S.A.
Domicilio del fondo: Luxembourg
Permesso di distribuzione: Austria, Germany, Switzerland, United Kingdom
Gestore del fondo: Matthew Cohen, Holly Fleiss, Dom Valder
Volume del fondo: 4.14 bill.  USD
Data di lancio: 01/02/2013
Investment focus: -

Condizioni

Sovrapprezzo emissione: 5.00%
Tassa amministrativa massima: 1.50%
Investimento minimo: 35,000.00 EUR
Deposit fees: -
Redemption charge: 0.50%
Prospetto semplificato: Download (Print version)
 

Società d'investimento

Funds company: JPMorgan AM (EU)
Indirizzo: PO Box 275, 2012, Luxembourg
Paese: Luxembourg
Internet: www.jpmorganassetmanagement.de
 

Attività

Stocks
 
98.72%
Mutual Funds
 
1.28%

Paesi

United States of America
 
77.49%
Denmark
 
6.39%
United Kingdom
 
6.08%
Switzerland
 
3.39%
France
 
2.31%
Japan
 
1.52%
Netherlands
 
0.89%
Germany
 
0.67%
Altri
 
1.26%

Filiali

Pharma/Biotechnology
 
54.15%
Healthcare services
 
24.31%
Healthcare appliances
 
16.91%
Parma, wholesale
 
1.71%
Gesundheitswesen/ Informationstechnologie
 
1.64%
Altri
 
1.28%